GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: Still a controversy?

27Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

Purpose: An update on the subject of ovarian hyperstimulation syndrome (OHSS) prevention with GnRH agonist ovulation trigger. Methods: Review of pertinent English language studies published during the past 4 years. Results: Randomized prospective studies support the notion that agonist trigger completely eliminates OHSS. Conflicting results regarding on going pregnancy rate probably reflect different approaches to luteal phase support. Embryos obtained and frozen after agonist trigger yield good clinical outcome in subsequent thaw cycles. Conclusions: The notion that agonist trigger can eliminate OHSS is strongly supported by randomized controlled trials. Further research is needed to assess optimal luteal support post agonist trigger. © 2008 Springer Science+Business Media, LLC.

Cite

CITATION STYLE

APA

Kol, S., & Solt, I. (2008, March). GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: Still a controversy? Journal of Assisted Reproduction and Genetics. https://doi.org/10.1007/s10815-008-9198-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free